摘要
目的探讨甲磺酸倍他司汀(敏使朗)治疗椎基底动脉供血不足性眩晕的效果。方法 100例椎基底动脉供血不足性眩晕患者,以良好的控制原发病为基础,随机分成两组,治疗组予以敏使朗12mg3次/d口服,对照组予以尼莫地平片40mg3次/d口服。14d/疗程。结果治疗组的总有效率为92%,起效较快。对照组总有效率为76%,起效较慢。两组总有效率相比,差异有统计学意义(P<0.01)。结论椎基底动脉供血不足性眩晕应用敏使朗治疗疗效显著。
Objective To investigate the treatment effect of Betahistine mesylate （min shi lang） on the vertebrobasilar insufficiency vertigo. Methods 100 cases of vertebrobasilar insufficiency vertigo patients, in the basis of primary disease good controlled divided into two groups, each group of 50 cases, the treatment group received oral Betahistine mesylate 12 rag, 3 times a day, control group oral nimodipine piece of 40 rag, 3 times a day. Two groups were to 14 clays for a period of treatment. Results The treatment group work faster, the total effective rate was 92%, the comparison group work slowly, the total effective rate was 76%, two groups of comparative statistics processing results have significant difference （/9〈0.01）. Conclusion Betahistine mesylate treatment vertebrobasilar insufficiency vertigo has significant clinical curative effect.
出处
《中外医疗》
2013年第6期107-107,109,共2页
China & Foreign Medical Treatment
关键词
椎基底动脉供血不足眩晕
敏使朗
治疗效果
Vertebrobasilar insufficiency vertigo
Betahistine mesylate
Treatment effect
